ANNEXON

annexon-logo

Annexon is a technology consulting and software solutions company.

#SimilarOrganizations #Website #More

ANNEXON

Social Links:

Industry:
Consulting Information Technology Software

Address:
Wembley, Brent, United Kingdom

Country:
United Kingdom

Website Url:
http://www.annexon.com

Total Employee:
1+

Status:
Active


Similar Organizations

cms-it-services-logo

CMS IT-Services

CMS IT-Services is an IT consulting and software company.

egeneration-logo

eGeneration

eGeneration is an IT consulting and software solution company.

hys-enterprise-logo

HYS Enterprise

HYS Enterprise is an IT consulting and software development company.

inspired-infotech-logo

Inspired Infotech

Inspired Infotech is a technology consulting and software solutions company.

kutzner-logo

Kutzner

Kutzner is an IT consulting and software development company.

novacroft-logo

Novacroft

Novacroft is a technology and software solutions company.

ras-logo

RAS

RAS is an IT consulting and software developing company.

silitech-consulting-logo

Silitech Consulting

Silitech Consulting is an IT consulting and software development company.

tecnologia-familiar-logo

Tecnologia Familiar

Tecnologia Familiar is an information technology consulting and software development company.

Official Site Inspections

http://www.annexon.com

  • Host name: just2056.justhost.com
  • IP address: 173.254.29.33
  • Location: Provo United States
  • Latitude: 40.2342
  • Longitude: -111.6442
  • Metro Code: 770
  • Timezone: America/Denver
  • Postal: 84606

Loading ...

More informations about "Annexon"

Annexos โ€“ Annexos

Annexos is a strategic, mission-focused company providing modern services and solutions to the public sector. As a Woman-Owned Small Business (WOSB), we are committed to innovative โ€ฆSee details»

Annexon, Inc. (ANNX) Company Profile & Facts - Yahoo Finance

See the company profile for Annexon, Inc. (ANNX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โ€ฆSee details»

Annexon : IT Consultancy | Software Services | Technology โ€ฆ

Annexon is an IT software and services company, providing consultancy, end-to-end solutions, bespoke product development and support services to meet wide range of your business needs.See details»

Annexus® โ€“ Building Smarter Retirements.

Nov 19, 2024 BUILDING SMARTER RETIREMENTS. We are the leading independent retirement planning product design and distribution company in America. Our solutions provide โ€ฆSee details»

Annexon, Inc. Company Profile | Brisbane, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Annexon, Inc. of Brisbane, CA. Get the latest business insights from Dun & Bradstreet.See details»

Org Chart Annexon - The Official Board

The organizational chart of Annexon displays its 16 main executives including Douglas Love, Jennifer Lew, Shikhar Agarwal and Lori TaylorSee details»

Annexon, Inc. (ANNX) Company Profile & Overview - Stock Analysis

Jul 24, 2020 Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an โ€ฆSee details»

Working At Annexon: Company Overview and Culture - Zippia

Organization Type. Public. CEO. Douglas Love. Social Media. Annexon Biosciences is the development of therapeutic products that halt the progression of complement-mediated โ€ฆSee details»

Annexon Inc, ANNX:NSQ profile - FT.com - Financial Times

Annexon, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in advancing a late-stage clinical platform of therapies for people living with classical complement โ€ฆSee details»

Annexon Biosciences - Crunchbase Company Profile & Funding

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.See details»

Annexon Biosciences - The Org

Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, โ€ฆSee details»

Annexon, Inc. (ANNX) Company Profile & Facts - Yahoo Finance

See the company profile for Annexon, Inc. (ANNX) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โ€ฆSee details»

Contacts, Employees, Board Members, Advisors & Alumni

Organization. Annexon Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 10. Number of โ€ฆSee details»

Annexon Biosciences - AnnualReports.com

Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, โ€ฆSee details»

Home - Annexon Biosciences

Unlocking the next generation of complement therapies We are focused on stopping C1q, the initiating molecule of the classical complement pathway, at the start to treat devastating โ€ฆSee details»

Annexon Highlights Strategic Focus to Advance Four Flagship โ€ฆ

Jan 8, 2023 Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in Multiple Disease Indications Well-Capitalized with Operating Runway โ€ฆSee details»

Annexon, Inc. (ANNX) Interactive Stock Chart - Yahoo Finance

Interactive Chart for Annexon, Inc. (ANNX), analyze all the data with a huge range of indicators.See details»

Annexon Outlines 2024 Priorities with Late-Stage Clinical โ€ฆ

Jan 8, 2024 ANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024; Potential to be First Approved Treatment for GBS Patients in the U.S. ANX007 โ€ฆSee details»

Annexon Biosciences - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

Promising Outlook for Annexonโ€™s ANX005 in GBS Treatment: A ...

Mar 4, 2024 Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain โ€ฆSee details»

linkstock.net © 2022. All rights reserved